Medlex's banner
   :: Home:: Products & Services




Products:

PharmAssist Enterprise-Wide Decision Support Solution:

What Is The PharmAssist Enterprise-Wide Decision Support Solution? -- The PharmAssist enterprise-wide decision support solution is a state-of-the-art computer-based software technology that can:

  • help lower risks associated with drug development by providing decision analysis results that have greater credibility than can be obtained from other decision support technologies
  • accelerate the drug development process by reducing the time needed to make critical decisions
  • provide a corporate-wide, seamlessly integrated, and structured environment for decision making

What Does PharmAssist Do? -- PharmAssist can help:

  • identify, evaluate, and prioritize the potential of new target identifications, target validations, lead identifications, and lead optimizations
  • determine the drug candidates that are most appropriate to move on to clinical trials
  • calculate current and projected portfolio valuations and ROI
  • conduct "what if" scenarios
  • produce audit trails of decision-making activities

What Does PharmAssist Tell Me? -- The output from PharmAssist informs the user about:

  • the prioritization of alternative actions. For example, which drugs to move on to clinical trials. Which new drug target has the greatest potential. Which portfolio projects deserve increased investment, or should be dropped, delayed, or shelved.
  • which information and assumptions have the greatest or least impact on results.
  • the degree of risk that is associated with alternative decisions.
  • risk versus reward, ROI, and NPV.

Who Will Use PharmAssist? -- Staff, project leaders, managers, directors, VPs, CFOs, CEOs, COOs that have to make decisions about manufacturing, drug discovery, drug development, clinical trials, finance, and portfolio management.

What Are The Features And Benefits Of Using PharmAssist?

  • Features --
    • Decision support engine that is superior to currently available traditional probabilistic-based products
    • Computational infrastructure that supports integrating decision making on a corporate-wide basis
    • Decision support models for all stages of drug development; from drug discovery and development through portfolio management and making strategic business decisions
    • Customizable decision support models, to suit particular corporate decision-making needs and requirements
    • Compatibility with existing legacy DB, spreadsheet, and project management systems
    • Technology that allows users to acquire instant or continuous snapshots and projections of corporate-wide portfolio valuation, risks, and ROI
  • Benefits--
    • Faster and more accurate decision making increases ability to identify and eliminate least promising drug candidates -- thus, creating opportunity for a higher percentage of successful drugs to make it to market
    • Structured and corporate-wide organized approach facilitates rapid and more accurate decision making.
    • Audit trail of decision making facilitates continuous improvement of decision making capabilities

PharmAssist Model Development Environment:

The PharmAssist model development environment is a software development system that allows users to modify, extend, or create decision support models for use by the PharmAssist Enterprise-Wide Decision Support Solution. This product is needed if the user wishes to integrate corporate specific or proprietary information into decision support modules.

Services:

Consulting -- Assistance with the design, development, and use of decision support models and decision analysis techniques using PharmAssist products.

Customization -- Design, develop, and implement graphical user interfaces (GUIs) and decision analysis methods to suite user needs and requirements.

Technical Support -- Product upgrades and bug fixes for subscribed users.

Training -- Instruction on how to use PharmAssist products and obtain the greatest benefit from MedLex's technologies.


  SPOTLIGHT

Copyright © 2004-2005. MedLex Inc. All rights reserved.